(1R,2R)-2-[4-(3-메틸-1H-피라졸-5-일)벤조일]-N-(4-옥소-4,5,6,7-테트라하이드로피라졸로[1,5-A]피라진-3-일)사이클로헥산카복스아미드의 결정형

(1,2)-2-[4-(3-메틸-1-피라졸-5-일)벤조일]--(4-옥소-4,5,6,7-테트라하이드로피라졸로[1,5-]피라진-3-일)사이클로헥산카복스아미드의 결정형, 그를 함유하는 약제학적 조성물 및 치료법에서의 그의 용도. A crystalline form of (1R,2R)-2-[4-(3-Methyl-1H-pyrazol-5-yl)benzoyl]-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexanecarboxamide, pharmaceutical compositions...

Full description

Saved in:
Bibliographic Details
Main Author PETTERSEN ANNA MATILDA ANGELICA
Format Patent
LanguageKorean
Published 24.06.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:(1,2)-2-[4-(3-메틸-1-피라졸-5-일)벤조일]--(4-옥소-4,5,6,7-테트라하이드로피라졸로[1,5-]피라진-3-일)사이클로헥산카복스아미드의 결정형, 그를 함유하는 약제학적 조성물 및 치료법에서의 그의 용도. A crystalline form of (1R,2R)-2-[4-(3-Methyl-1H-pyrazol-5-yl)benzoyl]-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexanecarboxamide, pharmaceutical compositions containing it and its use in the prevention or treatment of cardiovascular diseases.
Bibliography:Application Number: KR20197014045